Specialty diets
The Biggest Lie About Specialty Dietary Foods vs Profits
Specialty nutrition is growing at a 15% annual rate, and Aboitiz’s Diasham acquisition could raise revenues by about 20% in three years, making the risk appear justified. The deal also expands the company’s ability to serve patients who need precise nutrient formulations, such as those with phenylketonuria. Medical